Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 02-2016 | 12-2015 | 03-2015 | 02-2015 | 12-2014 | |
| Sales | 29 | 29 | 29 | 0 | 240 |
| Cost of Goods | 63 | 63 | 63 | N/A | 200 |
| Gross Profit | -34 | -30 | 30 | N/A | 30 |
| Operating Expenses | 7,403 | 7,331 | 7,534 | 0 | 11,060 |
| Operating Income | -7,374 | -7,365 | -7,505 | N/A | -11,020 |
| Interest Expense | 2 | 2 | 2 | 0 | 0 |
| Other Income | 2,529 | 2,520 | 2,660 | 0 | 9,550 |
| Pre-tax Income | -4,846 | -4,846 | -4,846 | 0 | -1,470 |
| Net Income Continuous | -4,846 | -4,846 | -1,338 | N/A | -1,338 |
| Net Income | $-4,846 | $-4,846 | $-4,846 | $N/A | $-1,470 |
| EPS Basic Total Ops | -21.74 | -0.45 | -9.60 | N/A | -0.20 |
| EPS Basic Continuous Ops | -21.82 | -0.45 | -7.76 | N/A | -0.16 |
| EPS Diluted Total Ops | -21.74 | -0.45 | -9.60 | N/A | -0.20 |
| EPS Diluted Continuous Ops | -21.82 | -0.45 | -7.76 | N/A | -0.16 |
| EBITDA(a) | $-5,537 | $-6,015 | $-5,435 | $N/A | $-9,460 |